N. Shohat Et Al. , "2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY," BONE & JOINT JOURNAL , no.7, pp.3-9, 2019
Shohat, N. Et Al. 2019. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY. BONE & JOINT JOURNAL , no.7 , 3-9.
Shohat, N., Tarabichi, M., Tan, T. L., Goswami, K., Kheir, M., Malkani, A. L., ... Shah, R. P.(2019). 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY. BONE & JOINT JOURNAL , no.7, 3-9.
Shohat, N. Et Al. "2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY," BONE & JOINT JOURNAL , no.7, 3-9, 2019
Shohat, N. Et Al. "2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY." BONE & JOINT JOURNAL , no.7, pp.3-9, 2019
Shohat, N. Et Al. (2019) . "2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY." BONE & JOINT JOURNAL , no.7, pp.3-9.
@article{article, author={N. Shohat Et Al. }, title={2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty A PROSPECTIVE MULTICENTRE STUDY}, journal={BONE & JOINT JOURNAL}, year=2019, pages={3-9} }